Rare diseases
Investigational molecules
Locations
Study on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis
The NetherlandsStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
The NetherlandsStudy of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases
The NetherlandsStudy Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression
The NetherlandsStudy of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors
The NetherlandsStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
The NetherlandsStudy on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)
The NetherlandsStudy on Imlifidase for Treating Acute Inflammation in Patients with Neuromyelitis Optica Spectrum Disorder
The NetherlandsStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsStudy of Pembrolizumab for Patients with Vulvar Squamous Cell Carcinoma
The NetherlandsStudy of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy
The NetherlandsStudy Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
